Back to search

Article

The genetics and kinetics of BCL2 driven lymphoid malignancies

2015-01-01

Abstract excerpt

Introduction: Non-Hodgkin Lymphoma (NHL) is rising in incidence. Treatment of this genetically heterogeneous disease has toxic side effects and significant numbers of relapsers / non-responders. BCL2, an anti-apoptotic protein, is commonly overexpressed in NHL as a result of the t(14;18) translocation. A number of BCL2 inhibitors have shown success in clinical trials but variable efficacy has meant that none have...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6bbaf751-7647-5615-be12-8211a437ff28
DOI
10.25560/45406
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The genetics and kinetics of BCL2 driven lymphoid malignanciesDOI 10.25560/45406
Select a neighboring publication to make it the new centre.